|
Market Cap | 3.78M | EPS (ttm) | -9.64 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -42.75% |
P/S | 0.57 | EPS next 5Y | - |
P/B | 0.50 | EPS Q/Q | 79.05% |
Dividend | - | Sales Q/Q | -45.15% |
Insider Own | 14.03% | Inst Own | 13.06% |
Insider Trans | 0.00% | Inst Trans | 0.96% |
Short Float | 11.42% | Earnings | - |
Analyst Recom | 1.00 | Target Price | 4.00 |
Avg Volume | 61.50K | 52W Range | 0.40 - 1.85 |
|
|
|
Arcimoto, Inc. engages in the design, development, manufacture, sale, and rental of three-wheeled electric vehicles. Its products include Fun Utility Vehicle, Rapid Responder, Deliverator, Cameo, Flatbed, Mean Lean Machine, and Roadster. It operates through the following segments: Fun Utility Vehicles (FUV), Rental, and TMW. The FUV segment includes the sale of electric vehicle product lines. The Rental segment is involved in short-term rental of electric vehicles via various channels or networks. The TMW segment engages in the design, production, sales, and installation of a bolt on kit that converts a two wheeled motorcycle into a tilting three wheeled motorcycle. The company was founded by Mark D. Frohnmayer on November 21, 2007 and is headquartered in Eugene, OR. |
|
|
|
Market Cap | 4.52M | EPS (ttm) | -7.90 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 29.34% |
P/S | 113.12 | EPS next 5Y | - |
P/B | 1.98 | EPS Q/Q | -356.71% |
Dividend | - | Sales Q/Q | - |
Insider Own | 11.83% | Inst Own | 1.39% |
Insider Trans | -0.66% | Inst Trans | 28.33% |
Short Float | 0.90% | Earnings | - |
Analyst Recom | 1.00 | Target Price | 90.00 |
Avg Volume | 99.79K | 52W Range | 1.01 - 7.74 |
|
|
|
Oragenics, Inc. operates as a development-stage company, which engages in research and development of potential therapies to fight infectious diseases including coronaviruses and multidrug-resistant organisms. Its technology and pipeline consist of antibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Telling Fred | Director | Nov 30 '23 | Sale | 3.57 | 3,500 | 12,488 | 38,345 | Dec 01 05:23 PM |
|
|
|
|
Market Cap | 19.10M | EPS (ttm) | -1.33 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 22.21% |
P/S | 0.14 | EPS next 5Y | - |
P/B | 6.46 | EPS Q/Q | -3.07% |
Dividend | 17.93% | Sales Q/Q | -13.09% |
Insider Own | 18.36% | Inst Own | 24.72% |
Insider Trans | 0.00% | Inst Trans | -5.56% |
Short Float | 2.17% | Earnings | Mar 07/b |
Analyst Recom | - | Target Price | - |
Avg Volume | 35.66K | 52W Range | 3.55 - 5.13 |
|
|
|
DallasNews Corp. is a news and information publishing company, which owns and operates commercial printing, distribution, and direct mail service businesses. It operates through the following segments: Publishing and Marketing. The Publishing segment includes the operations of The Dallas Morning News and various niche publications targeting specific audiences. The Marketing segment focuses on the marketing services generated by DMV Holdings and its subsidiaries, Distribion, Vertical Nerve, and MarketingFX. The company was founded on April 11, 1842 and is headquartered in Dallas, TX. |
|
| |
|
Market Cap | 1.36M | EPS (ttm) | -0.72 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 68.20 | EPS next 5Y | - |
P/B | 168.48 | EPS Q/Q | -78.19% |
Dividend | - | Sales Q/Q | - |
Insider Own | 36.91% | Inst Own | 7.18% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 1.70% | Earnings | - |
Analyst Recom | 1.00 | Target Price | 14.00 |
Avg Volume | 47.37K | 52W Range | 0.72 - 17.00 |
|
|
|
Lucy Scientific Discovery, Inc. is an early-stage company, which engages in the manufacture of psychotropics contracts. It focuses on the research, development, and manufacture of psychotropics-based medicines. Its products include raw materials, crude extracts, targeted formulations, white and private label products, and single molecule fractions. The company was founded on February 17, 2017 and is headquartered in Victoria, Canada. |
|
|
|
Market Cap | 52.61M | EPS (ttm) | 0.91 |
P/E | 4.45 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | 1.65 | EPS past 5Y | -3.56% |
P/S | 0.20 | EPS next 5Y | 2.70% |
P/B | 0.21 | EPS Q/Q | 153.33% |
Dividend | - | Sales Q/Q | -12.80% |
Insider Own | 12.02% | Inst Own | 86.94% |
Insider Trans | -1.37% | Inst Trans | -1.47% |
Short Float | 10.30% | Earnings | Nov 16/b |
Analyst Recom | 3.00 | Target Price | 17.00 |
Avg Volume | 180.41K | 52W Range | 4.05 - 30.40 |
|
|
|
Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include RYANODEX, BENDEKA and BELRAPZO. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Tarriff Scott | CEO | Nov 02 '23 | Sale | 13.87 | 10,694 | 148,326 | 545,447 | Nov 03 04:39 PM | Tarriff Scott | CEO | Nov 01 '23 | Sale | 13.82 | 10,925 | 150,984 | 556,141 | Nov 03 04:39 PM | Graves Michael | Director | Oct 27 '23 | Option Exercise | 4.94 | 9,360 | 46,238 | 10,360 | Oct 31 05:41 PM | Tarriff Scott | CEO | Oct 03 '23 | Sale | 14.46 | 10,734 | 155,174 | 567,066 | Oct 04 05:07 PM | Tarriff Scott | CEO | Oct 02 '23 | Sale | 15.23 | 9,511 | 144,853 | 577,800 | Oct 04 05:07 PM |
|
|
| |
|
Market Cap | 1.04B | EPS (ttm) | 0.47 |
P/E | 22.38 | EPS this Y | -118.11% |
Forward P/E | 75.83 | EPS next Y | 265.27% |
PEG | 2.17 | EPS past 5Y | - |
P/S | 1.61 | EPS next 5Y | 10.30% |
P/B | 123.32 | EPS Q/Q | -67.13% |
Dividend | - | Sales Q/Q | -35.42% |
Insider Own | 30.23% | Inst Own | 49.70% |
Insider Trans | -0.98% | Inst Trans | -1.83% |
Short Float | 4.77% | Earnings | May 09/a |
Analyst Recom | 2.38 | Target Price | 14.20 |
Avg Volume | 544.97K | 52W Range | 10.27 - 19.29 |
|
|
|
ZipRecruiter, Inc. operates as web-based hiring platform for small and medium sized businesses. It streamlines the hiring process and offers reseller programs, ATS integrations, and email alert program. The company was founded by Ian Siegel, Joe Edmonds, Ward Poulos, and Willis Redd in 2010 and is headquartered in Santa Monica, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
YARBROUGH TIMOTHY G. | EVP & CHIEF FINANCIAL OFFICER | Apr 19 '24 | Sale | 10.47 | 6,013 | 62,937 | 180,682 | Apr 22 04:55 PM | SAKAMOTO RYAN T. | EVP, CHIEF LEGAL OFFICER | Apr 19 '24 | Sale | 10.47 | 1,357 | 14,203 | 96,192 | Apr 22 04:54 PM | SHIMANOVSKY BORIS F. | EVP & CHIEF TECHNOLOGY OFFICER | Mar 21 '24 | Sale | 12.00 | 5,200 | 62,400 | 224,182 | Mar 21 08:37 PM | TRAVERS DAVID | PRESIDENT | Mar 21 '24 | Sale | 11.88 | 849 | 10,087 | 1,086,401 | Mar 21 08:35 PM | TRAVERS DAVID | PRESIDENT | Mar 20 '24 | Sale | 11.74 | 31,621 | 371,180 | 1,086,401 | Mar 21 08:35 PM |
|
|
|
|
Market Cap | 13.60M | EPS (ttm) | -6.01 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -24.31% |
P/S | 0.24 | EPS next 5Y | 15.00% |
P/B | - | EPS Q/Q | -171.34% |
Dividend | - | Sales Q/Q | -25.55% |
Insider Own | 3.57% | Inst Own | 39.26% |
Insider Trans | 0.00% | Inst Trans | -9.83% |
Short Float | 0.03% | Earnings | Apr 04/b |
Analyst Recom | 1.00 | Target Price | 20.00 |
Avg Volume | 97.37K | 52W Range | 1.79 - 5.50 |
|
|
|
Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland. |
|
| |
|
Market Cap | 417.17M | EPS (ttm) | 1.72 |
P/E | 23.91 | EPS this Y | -9.47% |
Forward P/E | 11.72 | EPS next Y | 103.49% |
PEG | 1.71 | EPS past 5Y | -14.37% |
P/S | 0.67 | EPS next 5Y | 14.00% |
P/B | 0.83 | EPS Q/Q | -33.07% |
Dividend | 3.17% | Sales Q/Q | -22.26% |
Insider Own | 18.23% | Inst Own | 66.47% |
Insider Trans | 0.00% | Inst Trans | -1.60% |
Short Float | 4.58% | Earnings | May 03/b |
Analyst Recom | 1.00 | Target Price | 117.00 |
Avg Volume | 46.59K | 52W Range | 41.16 - 64.71 |
|
|
|
Johnson Outdoors, Inc. engages in the manufacturing and marketing of seasonal, outdoor recreation products. It operates through the following segments: Fishing, Camping, Watercraft Recreation, Diving, and Other. The Fishing segment includes the brands Minn Kota electric motors for quiet trolling or primary propulsion, marine battery chargers, and shallow water anchors, Humminbird sonar and GPS equipment for fishfinding, navigation and marine cartography, and Cannon downriggers for controlled-depth fishing. The Camping segment consists of Eureka! Consumer, commercial and military tents and accessories, sleeping bags, camping furniture and stoves and other recreational camping products, and Jetboil portable outdoor cooking systems. The Watercraft Recreation segment designs and markets canoes and kayaks, including pedal-driven and Minn Kota motor-driven kayaks, under the Ocean Kayaks and Old Town brand names for family recreation, touring, angling, and tripping. The Diving segment sells and distributes the SCUBAPRO brand. The company was founded by Samuel Curtis Johnson II in 1970 and is headquartered in Racine, WI. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Johnson David W | Vice President and CFO | Sep 13 '23 | Sale | 54.85 | 1,000 | 54,850 | 26,857 | Sep 13 12:19 PM | Johnson David W | Vice President and CFO | Jun 12 '23 | Sale | 60.04 | 1,000 | 60,040 | 27,857 | Jun 13 11:03 AM | FAHEY JOHN M JR | Director | Jun 02 '23 | Sale | 58.50 | 1,279 | 74,826 | 16,509 | Jun 05 11:14 AM |
|
|
|
|
Market Cap | 240.12M | EPS (ttm) | 3.94 |
P/E | 3.17 | EPS this Y | 0.38% |
Forward P/E | 2.36 | EPS next Y | 3.66% |
PEG | - | EPS past 5Y | -12.26% |
P/S | 0.66 | EPS next 5Y | - |
P/B | - | EPS Q/Q | 7.52% |
Dividend | - | Sales Q/Q | -2.75% |
Insider Own | 8.12% | Inst Own | 97.09% |
Insider Trans | 0.00% | Inst Trans | 7.06% |
Short Float | 3.47% | Earnings | May 08/a |
Analyst Recom | 2.33 | Target Price | 23.80 |
Avg Volume | 404.39K | 52W Range | 12.25 - 38.34 |
|
|
|
Consensus Cloud Solutions, Inc. provides digital cloud fax technology, with a scalable software-as-a-service (SaaS) platform. Its products and solutions include eFax Corporate, Unite, jSign, Signal, Clarity and eFax. The company was founded on May 24, 2021 and is headquartered in Los Angeles, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
MALONE JAMES C | Chief Financial Officer | May 11 '23 | Buy | 33.98 | 4,500 | 152,910 | 17,091 | May 12 04:30 PM |
|
|
|
|
Market Cap | 3.83M | EPS (ttm) | -8.72 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 62.30% |
P/S | 1.74 | EPS next 5Y | - |
P/B | - | EPS Q/Q | 89.34% |
Dividend | - | Sales Q/Q | - |
Insider Own | 8.70% | Inst Own | 14.97% |
Insider Trans | 15.39% | Inst Trans | -50.99% |
Short Float | 5.48% | Earnings | - |
Analyst Recom | 1.00 | Target Price | 4.00 |
Avg Volume | 441.30K | 52W Range | 0.28 - 49.80 |
|
|
|
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The company was founded by Raj Mehra in 1987 and is headquartered in New York, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Mehra Raj | See Remarks | Dec 01 '23 | Buy | 1.32 | 75,757 | 99,999 | 185,142 | Dec 01 04:16 PM | Golembiewski Michael Joseph | Chief Financial Officer | Nov 30 '23 | Buy | 1.21 | 83,000 | 100,222 | 86,450 | Dec 01 04:16 PM |
|
|
|